Prelude Therapeutics Incorporated (PRLD) Earnings
NASDAQ·Healthcare·Biotechnology
$4.29
-5.20%
Mkt Cap $170.52M
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
-$0.24
1 analysts
Revenue Estimate
$5.88M
Last quarter: beat by +39.39% on EPS, -72.68% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$170.52M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58